Breaking News Instant updates and real-time market news.

HPQ

HP Inc.

$18.91 /

-0.04 (-0.21%)

06:46
08/23/19
08/23
06:46
08/23/19
06:46

HP Inc. price target lowered to $20 from $23 at Wells Fargo

Wells Fargo analyst Aaron Rakers lowered his price target for HP Inc to $20 from $23 and maintained a Market Perform rating, saying the company delivered what he expects to be considered net-negative third quarter results. In a research note to investors, Rakers says that while HP reported strong PC results and execution, he thinks investors will now focus on tough comps into fiscal 2020 with a maturing Windows 10 commercial upgrade cycle and component price decline pass-through.

  • 10

    Sep

HPQ HP Inc.
$18.91 /

-0.04 (-0.21%)

08/23/19 Citi
HP Inc. 'surprises' add uncertainty for investors, says Citi
08/23/19 Evercore ISI
HP Inc. downgraded In Line at Evercore ISI
08/20/19
Fly Intel: Top five analyst downgrades
08/20/19 Citi
HP Inc. downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

Earnings
Marriott reports Q2 adjusted EPS (64c), consensus (42c) » 07:00
08/10/20
08/10
07:00
08/10/20
07:00
MAR

Marriott

$93.80 /

+3.41 (+3.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

07/02/20 Citi
Marriott price target raised to $95 from $75 at Citi
06/25/20 Gordon Haskett
Marriott initiated with a Hold at Gordon Haskett
06/23/20 Nomura Instinet
Marriott price target raised to $148 from $123 at Nomura Instinet
06/22/20 Barclays
Barclays turns positive on lodging, upgrades Marriott to Overweight
MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

MAR Marriott
$93.80 /

+3.41 (+3.77%)

Upgrade
Fidus Investment upgraded to Buy at Ladenburg with credit holding up well » 07:00
08/10/20
08/10
07:00
08/10/20
07:00
FDUS

Fidus Investment

$10.25 /

+1.42 (+16.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

06:39 Today Ladenburg
Fidus Investment upgraded to Buy from Neutral at Ladenburg
03/24/20 B. Riley FBR
Fidus Investment downgraded to Neutral from Buy at B. Riley FBR
03/17/20 National Securities
Fidus Investment upgraded to Buy from Neutral at National Securities
10/23/19 National Securities
Fidus Investment initiated with a Neutral at National Securities
FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

Hot Stocks
Eagle lowers R&D Non-GAAP expense view to $40M-$44M » 07:00
08/10/20
08/10
07:00
08/10/20
07:00
EGRX

Eagle Pharmaceuticals

$46.88 /

-0.61 (-1.28%)

As a result of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGRX Eagle Pharmaceuticals
$46.88 /

-0.61 (-1.28%)

EGRX Eagle Pharmaceuticals
$46.88 /

-0.61 (-1.28%)

Hot Stocks
Mallinckrodt announces FDA filing acceptance of BLA for StrataGraft » 07:00
08/10/20
08/10
07:00
08/10/20
07:00
MNK

Mallinckrodt

$1.44 /

-0.12 (-7.69%)

Mallinckrodt said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

08/06/20 Citi
Mallinckrodt price target lowered to $1 from $2 at Citi
08/05/20 BMO Capital
Mallinckrodt price target lowered to $2 from $4 at BMO Capital
08/04/20 Piper Sandler
Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler
07/14/20 BMO Capital
Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital
MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

MNK Mallinckrodt
$1.44 /

-0.12 (-7.69%)

Initiation
nCino initiated with a Market Perform at Raymond James » 06:59
08/10/20
08/10
06:59
08/10/20
06:59
NCNO

nCino

$75.71 /

+0.21 (+0.28%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$75.71 /

+0.21 (+0.28%)

06:57 Today KeyBanc
KeyBanc bullish on nCino, initiates with an Overweight
06:19 Today BofA
nCino initiated with a Buy at BofA
06:14 Today Piper Sandler
nCino initiated with an Overweight at Piper Sandler
06:10 Today Barclays
nCino initiated with an Equal Weight at Barclays
  • 14
    Jul
NCNO nCino
$75.71 /

+0.21 (+0.28%)

NCNO nCino
$75.71 /

+0.21 (+0.28%)

Hot Stocks
Sempra says Cameron LNG reaches full commercial operations » 06:58
08/10/20
08/10
06:58
08/10/20
06:58
SRE

Sempra Energy

$129.95 /

+1.705 (+1.33%)

Sempra Energy said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$129.95 /

+1.705 (+1.33%)

SRE Sempra Energy
$129.95 /

+1.705 (+1.33%)

07/21/20 KeyBanc
KeyBanc upgrades Sempra Energy to Overweight with $141 target
07/21/20 KeyBanc
KeyBanc downgrades DTE Energy, prefers Sempra for cyclical exposure
07/21/20 KeyBanc
Sempra Energy upgraded to Overweight from Sector Weight at KeyBanc
06/15/20 Seaport Global
Seaport Global starts Sempra Energy at Buy with $142 price target
SRE Sempra Energy
$129.95 /

+1.705 (+1.33%)

Syndicate
Wix.com announces private offering of $500M of convertible senior notes due 2025  06:57
08/10/20
08/10
06:57
08/10/20
06:57
WIX

Wix.com

$291.82 /

-15.89 (-5.16%)

 
ShowHide Related Items >><<
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

08/07/20 Oppenheimer
Wix.com price target raised to $350 from $305 at Oppenheimer
08/07/20 JMP Securities
Wix.com price target raised to $363 from $210 at JMP Securities
07/23/20 Citi
Wix.com price target raised to $330 from $220 at Citi
07/22/20 KeyBanc
Wix.com price target raised to $325 from $275 at KeyBanc
WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

WIX Wix.com
$291.82 /

-15.89 (-5.16%)

Earnings
Eagle Pharmaceuticals reports Q2 non-GAAP EPS 57c, consensus 23c » 06:57
08/10/20
08/10
06:57
08/10/20
06:57
EGRX

Eagle Pharmaceuticals

$46.88 /

-0.61 (-1.28%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGRX Eagle Pharmaceuticals
$46.88 /

-0.61 (-1.28%)

EGRX Eagle Pharmaceuticals
$46.88 /

-0.61 (-1.28%)

Initiation
KeyBanc bullish on nCino, initiates with an Overweight » 06:57
08/10/20
08/10
06:57
08/10/20
06:57
NCNO

nCino

$75.71 /

+0.21 (+0.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$75.71 /

+0.21 (+0.28%)

06:19 Today BofA
nCino initiated with a Buy at BofA
06:14 Today Piper Sandler
nCino initiated with an Overweight at Piper Sandler
06:10 Today Barclays
nCino initiated with an Equal Weight at Barclays
06:05 Today BofA
nCino initiated with a Buy at BofA
  • 14
    Jul
NCNO nCino
$75.71 /

+0.21 (+0.28%)

NCNO nCino
$75.71 /

+0.21 (+0.28%)

Recommendations
Facebook price target raised to $315 from $285 at Mizuho » 06:55
08/10/20
08/10
06:55
08/10/20
06:55
FB

Facebook

$268.52 /

+3.295 (+1.24%)

Mizuho analyst James Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

Hot Stocks
Pieris Pharmaceuticals, Eli Lilly enter into clinical trial collaboration » 06:55
08/10/20
08/10
06:55
08/10/20
06:55
PIRS

Pieris Pharmaceuticals

$2.68 /

-0.06 (-2.19%)

, LLY

Eli Lilly

$152.89 /

+0.01 (+0.01%)

Pieris Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

Earnings
Granite reports $463.6M of available liquidity at end of Q2 » 06:54
08/10/20
08/10
06:54
08/10/20
06:54
GVA

Granite Construction

$18.92 /

+0.775 (+4.27%)

The copany said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
01/13/20 Goldman Sachs
Granite Construction downgraded to Sell from Neutral at Goldman Sachs
10/28/19
Granite Construction downgraded to Neutral from Buy at DA Davidson
10/28/19 DA Davidson
Granite Construction downgraded to Neutral from Buy at DA Davidson
GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

GVA Granite Construction
$18.92 /

+0.775 (+4.27%)

Hot Stocks
Virtu Financial names Sean Galvin as new CFO, succeeding Alex Ioffe » 06:54
08/10/20
08/10
06:54
08/10/20
06:54
VIRT

Virtu Financial

$22.81 /

-1.8 (-7.31%)

Virtu Financial announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

06:34 Today Piper Sandler
Virtu Financial sell-off 'unwarranted,' says Piper Sandler
05/08/20 Compass Point
Virtu Financial price target raised to $28 from $23.50 at Compass Point
04/16/20 Rosenblatt
Virtu Financial downgraded to Neutral from Buy at Rosenblatt
03/04/20 JPMorgan
Virtu Financial price target raised to $23 from $20 at JPMorgan
VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

VIRT Virtu Financial
$22.81 /

-1.8 (-7.31%)

Earnings
Foot Locker not providing FY20 guidance at this time » 06:53
08/10/20
08/10
06:53
08/10/20
06:53
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

Foot Locker said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Hot Stocks
Foot Locker reports Q2 SSS up 18%  06:52
08/10/20
08/10
06:52
08/10/20
06:52
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

 
ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Earnings
Foot Locker sees Q2 EPS ex-itesm 66c-70c vs. 66c last year » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
FL

Foot Locker

$27.49 /

+0.54 (+2.00%)

Foot Locker provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

07/21/20 Deutsche Bank
Foot Locker named 'Short-Term Catalyst Buy Idea' at Deutsche Bank
07/10/20
Fly Intel: Top five analyst upgrades
07/10/20 Susquehanna
Foot Locker upgraded to Positive from Neutral at Susquehanna
06/22/20
Fly Intel: Top five analyst downgrades
FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

FL Foot Locker
$27.49 /

+0.54 (+2.00%)

Downgrade
OpenText downgraded to Sell from Buy at Veritas » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
OTEX

OpenText

$45.77 /

-0.525 (-1.13%)

Veritas analyst Howard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTEX OpenText
$45.77 /

-0.525 (-1.13%)

OTEX OpenText
$45.77 /

-0.525 (-1.13%)

05/01/20 TD Securities
OpenText price target raised to C$47 from C$45 at TD Securities
05/01/20 BMO Capital
BMO raises OpenText price target to C$61 after Q3 results
05/01/20 RBC Capital
OpenText's Q3 'effectively in line' with pre-COVID-19 estimates, says RBC
04/27/20 RBC Capital
OpenText price target lowered to $45 from $54 at RBC Capital
OTEX OpenText
$45.77 /

-0.525 (-1.13%)

OTEX OpenText
$45.77 /

-0.525 (-1.13%)

Hot Stocks
Synchronoss announces contract renewal with Verizon » 06:52
08/10/20
08/10
06:52
08/10/20
06:52
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

, VZ

Verizon

$58.52 /

+0.69 (+1.19%)

Synchronoss (SNCR)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
VZ Verizon
$58.52 /

+0.69 (+1.19%)

07/20/20 Needham
Infinera likely to join Ciena supplying 800G for Verizon, says Needham
07/08/20 JPMorgan
Nokia downgraded to Neutral from Overweight at JPMorgan
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/11/20 Wells Fargo
T-Mobile price target raised to $120 from $110 at Wells Fargo
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

VZ Verizon
$58.52 /

+0.69 (+1.19%)

Upgrade
Adient upgraded to Buy from Hold at Benchmark » 06:51
08/10/20
08/10
06:51
08/10/20
06:51
ADNT

Adient

$15.29 /

-0.385 (-2.46%)

Benchmark analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$15.29 /

-0.385 (-2.46%)

ADNT Adient
$15.29 /

-0.385 (-2.46%)

06:24 Today Benchmark
Adient upgraded to Buy from Hold at Benchmark
06/19/20 JPMorgan
Adient price target raised to $13 from $11 at JPMorgan
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 KeyBanc
Adient upgraded to Overweight from Sector Weight at KeyBanc
ADNT Adient
$15.29 /

-0.385 (-2.46%)

ADNT Adient
$15.29 /

-0.385 (-2.46%)

Hot Stocks
Reata Pharmaceuticals says pre-NDA meeting granted for Bardoxolone » 06:50
08/10/20
08/10
06:50
08/10/20
06:50
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Recommendations
Installed Building Products price target raised to $104 from $87 at Benchmark » 06:50
08/10/20
08/10
06:50
08/10/20
06:50
IBP

Installed Building Products

$85.92 /

+0.82 (+0.96%)

Benchmark analyst Reuben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

08/07/20 Zelman
Installed Building Products upgraded to Buy from Hold at Zelman
07/16/20 BTIG
Installed Building Products, Builders FirstSource price targets raised at BTIG
07/08/20 SunTrust
SunTrust ups Installed Building Products, TopBuild, Builders FirstSource targets
06/18/20 Benchmark
Installed Building Products price target raised to $87 from $63 at Benchmark
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

Earnings
Zynerba reports Q2 EPS (78c), consensus (45c) » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
ZYNE

Zynerba

$4.20 /

-0.08 (-1.87%)

As of June 30 cash and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

Upgrade
CF Industries upgraded to Buy from Neutral at Citi » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
CF

CF Industries

$33.13 /

-0.26 (-0.78%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

08/07/20
Fly Intel: Top five analyst upgrades
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
07/13/20
Fly Intel: Top five analyst upgrades
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

Initiation
GoHealth initiated with an Outperform at RBC Capital » 06:48
08/10/20
08/10
06:48
08/10/20
06:48
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

RBC Capital analyst Frank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
06:22 Today Truist
GoHealth initiated with a Buy at Truist
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Reata Pharmaceuticals reports Q2 adjusted EPS ($1.23), consensus ($2.84) » 06:47
08/10/20
08/10
06:47
08/10/20
06:47
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

Reports Q2 collaboration…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.